In a report released on December 21, Chris Lui from Jefferies maintained a Buy rating on Shandong Weigao Group Medical Polymer Co (SHWGF – Research Report), with a price target of HK$17.00. The company’s shares closed last Friday at $0.96.
According to TipRanks, Lui is an analyst with an average return of -14.1% and a 26.83% success rate. Lui covers the Healthcare sector, focusing on stocks such as Alibaba Health Information Technology, Innovent Biologics, and The United Laboratories International Holdings.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Shandong Weigao Group Medical Polymer Co with a $1.75 average price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $1.83 and a one-year low of $0.81. Currently, Shandong Weigao Group Medical Polymer Co has an average volume of 13K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Shandong Weigao Group Medical Polymer Co (SHWGF) Company Description:
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
